Xiaohan Zhai

922 total citations
31 papers, 745 citations indexed

About

Xiaohan Zhai is a scholar working on Molecular Biology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Xiaohan Zhai has authored 31 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Geriatrics and Gerontology and 6 papers in Oncology. Recurrent topics in Xiaohan Zhai's work include Sirtuins and Resveratrol in Medicine (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaohan Zhai is often cited by papers focused on Sirtuins and Resveratrol in Medicine (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaohan Zhai collaborates with scholars based in China. Xiaohan Zhai's co-authors include Jihong Yao, Xiaofeng Tian, Yan Hu, Musen Lin, Deshi Dong, Dongyan Gao, Shilei Yang, Linlin Lv, Xufeng Tao and Xiaochi Ma and has published in prestigious journals such as Scientific Reports, Critical Care Medicine and Frontiers in Immunology.

In The Last Decade

Xiaohan Zhai

29 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohan Zhai China 16 362 142 101 92 86 31 745
Xin Han China 20 460 1.3× 258 1.8× 134 1.3× 124 1.3× 96 1.1× 59 1.1k
Quan Jin China 19 366 1.0× 159 1.1× 106 1.0× 92 1.0× 65 0.8× 33 694
Zhixia Qiu China 21 448 1.2× 108 0.8× 159 1.6× 44 0.5× 87 1.0× 65 1.1k
Maysa A. Mobasher Saudi Arabia 12 211 0.6× 79 0.6× 114 1.1× 43 0.5× 46 0.5× 32 514
Shakir M. Saud United States 13 495 1.4× 107 0.8× 113 1.1× 68 0.7× 201 2.3× 15 1.0k
Daniel E. Francés Argentina 20 384 1.1× 276 1.9× 73 0.7× 61 0.7× 83 1.0× 38 950
Chao‐Yue Sun China 22 572 1.6× 123 0.9× 79 0.8× 135 1.5× 188 2.2× 36 1.1k
Jaime Arellanes‐Robledo Mexico 18 361 1.0× 234 1.6× 77 0.8× 116 1.3× 92 1.1× 52 822
Qianmei Zhou China 18 585 1.6× 105 0.7× 133 1.3× 67 0.7× 177 2.1× 45 1.0k

Countries citing papers authored by Xiaohan Zhai

Since Specialization
Citations

This map shows the geographic impact of Xiaohan Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Zhai more than expected).

Fields of papers citing papers by Xiaohan Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohan Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Zhai. The network helps show where Xiaohan Zhai may publish in the future.

Co-authorship network of co-authors of Xiaohan Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohan Zhai. A scholar is included among the top collaborators of Xiaohan Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohan Zhai. Xiaohan Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Musen, Yue Wang, Zhao Yan, et al.. (2025). Protective effects of albiflorin on acetaminophen-induced hepatotoxicity: Regulation of blood–biliary barrier integrity by ATF3. Phytomedicine. 141. 156722–156722.
3.
Ge, Wei, Zheng Dong, Ziyuan Wang, et al.. (2025). Solanesol: a promising natural product. Frontiers in Pharmacology. 16. 1504245–1504245. 1 indexed citations
4.
Wu, Yu, Fangyue Guo, Linlin Lv, et al.. (2025). Targeted inhibitors of S100A9 alleviate chronic pancreatitis by inhibiting M2 macrophage polarization via the TAOK3-JNK signaling pathway. Frontiers in Immunology. 16. 1526813–1526813. 1 indexed citations
5.
Song, Yifan, et al.. (2025). The role of gallic acid in liver disease: a review of its phytochemistry, pharmacology, and safety. Frontiers in Pharmacology. 16. 1595508–1595508.
6.
Zhai, Xiaohan, Yan Zhang, Yuhang Zhang, Miaorong Zhang, & Jianguo Tang. (2023). Facile fabrication of 3D honeycomb-like porous GaN photoanode for reliable and sensitive photoelectrochemical detection of glucose. Journal of Alloys and Compounds. 939. 168784–168784. 7 indexed citations
7.
Tao, Xufeng, Xiaohan Zhai, Zirui Zhao, et al.. (2023). Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology. 38(5). 1153–1161. 22 indexed citations
8.
Zhai, Xiaohan, Xufeng Tao, Shilei Yang, et al.. (2023). Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms. RSC Advances. 13(12). 7798–7817. 14 indexed citations
9.
Li, Xiaoyun, et al.. (2023). A novel mild etchant for photoelectrochemical etching of GaN with enhanced photoresponse. Materials Letters. 353. 135226–135226. 1 indexed citations
10.
Tao, Xufeng, Xiaohan Zhai, Yanna Zhu, et al.. (2023). Application of aptamer-drug delivery system in the therapy of breast cancer. Biomedicine & Pharmacotherapy. 161. 114444–114444. 42 indexed citations
11.
Tao, Xufeng, et al.. (2023). Machine Learning Techniques Applied to the Study of Drug Transporters. Molecules. 28(16). 5936–5936. 10 indexed citations
12.
Xiang, Hong, et al.. (2022). Metabolic reprogramming of immune cells in pancreatic cancer progression. Biomedicine & Pharmacotherapy. 157. 113992–113992. 42 indexed citations
13.
Lv, Linlin, Yanna Zhu, Xiaohan Zhai, et al.. (2022). Relationship between metabolic reprogramming and drug resistance in breast cancer. Frontiers in Oncology. 12. 942064–942064. 25 indexed citations
14.
Zhao, Yan, Zhecheng Wang, Dongcheng Feng, et al.. (2019). p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species. Theranostics. 9(5). 1510–1522. 84 indexed citations
15.
Su, Liping, Xiaohan Zhai, Ying Zhu, et al.. (2015). IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats. BMC Gastroenterology. 15(1). 77–77. 18 indexed citations
16.
Li, Mingzhu, Yang Lü, Yan Hu, et al.. (2014). Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats. Toxicology Letters. 228(2). 67–74. 62 indexed citations
17.
Hu, Yan, Jihong Yao, Xiaohan Zhai, et al.. (2014). Sirtuin 1-Mediated Inhibition of p66shc Expression Alleviates Liver Ischemia/Reperfusion Injury. Critical Care Medicine. 42(5). e373–e381. 50 indexed citations
18.
Zhang, Feng, Yan Hu, Xiaohan Zhai, et al.. (2014). Icariin protects against intestinal ischemia–reperfusion injury. Journal of Surgical Research. 194(1). 127–138. 29 indexed citations
19.
Chen, Zhao, Xiaohan Zhai, Yan Hu, et al.. (2014). Selective inhibition of protein kinase C β2 attenuates the adaptor P66Shc-mediated intestinal ischemia–reperfusion injury. Cell Death and Disease. 5(4). e1164–e1164. 27 indexed citations
20.
Hu, Yan, Xiaohan Zhai, Musen Lin, et al.. (2013). Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice. Toxicology and Applied Pharmacology. 273(1). 68–76. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Han Breakdown of academic impact, for papers by Quan Jin Breakdown of academic impact, for papers by Zhixia Qiu Breakdown of academic impact, for papers by Maysa A. Mobasher Breakdown of academic impact, for papers by Shakir M. Saud Breakdown of academic impact, for papers by Daniel E. Francés Breakdown of academic impact, for papers by Chao‐Yue Sun Breakdown of academic impact, for papers by Jaime Arellanes‐Robledo Breakdown of academic impact, for papers by Qianmei Zhou
Rankless by CCL
2026